Literature DB >> 14534773

Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study.

Hideaki Nagata1, Masahiro Nozaki, Hitoo Nakano.   

Abstract

The purpose of this study was to investigate whether it is possible to predict the long-term effects of estrogen replacement therapy (ERT) on lumbar bone mineral density (BMD) of oophorectomized women based on changes in BMD. In this study, we retrospectively investigated the changes in lumbar BMD of 70 oophorectomized women under ERT for more than 10 years, and examined whether it was possible in the early stage of ERT to predict the amount of lumbar BMD based on various parameters. Seventy oophorectomized Japanese women (56.8+/-3.9 years old) treated with conjugated equine estrogen (oral) at a dosage of 0.625 mg/day for 10 years were enrolled. Lumbar (L2-L4) BMD was measured annually by dual-energy X-ray absorptiometry (DXA; CV<1.0%). The correlation between changes in BMD after 10 years on ERT (DeltaBMD10) and several clinical factors was examined using a stepwise multiple regression model. The change in BMD after 1 year on ERT (%DeltaBMD1) was the only independent factor that correlated with changes in BMD after 10 years on ERT; the coefficient of correlation was R(2)=0.557 ( R=0.750, P<0.001). Based on the %DeltaBMD1, the 70 women were divided into two groups: women with a positive change in the 1st year (%DeltaBMD1 >or=0%) in group A ( n=40) and those with a negative value in the first year ( %DeltaBMD1<0%) in group B ( n=30). We investigated the sensitivity and specificity in the coincidence of %DeltaBMD1 changes in BMD after 10 years on ERT. The %DeltaBMD1 coincided with changes in BMD after 10 years on ERT; the sensitivity was 92.5% and specificity was 70.0%. In conclusion, changes in lumbar BMD on ERT can be predicted from the changes in lumbar BMD at the end of the 1st year.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534773     DOI: 10.1007/s00198-003-1447-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

1.  Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.

Authors:  L E Nachtigall; R H Nachtigall; R D Nachtigall; E M Beckman
Journal:  Obstet Gynecol       Date:  1979-03       Impact factor: 7.661

2.  Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.

Authors:  M Komulainen; H Kröger; M T Tuppurainen; A M Heikkinen; R Honkanen; S Saarikoski
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

3.  Prediction of rapid bone loss in postmenopausal women.

Authors:  C Christiansen; B J Riis; P Rødbro
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

4.  Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

Authors: 
Journal:  JAMA       Date:  1996-11-06       Impact factor: 56.272

5.  Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.

Authors:  L S Richelson; H W Wahner; L J Melton; B L Riggs
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

6.  The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism.

Authors:  K Hashimoto; M Nozaki; Y Inoue; M Sano; H Nakano
Journal:  Maturitas       Date:  1995-11       Impact factor: 4.342

Review 7.  Postmenopausal osteoporosis.

Authors:  N B Watts
Journal:  Obstet Gynecol Surv       Date:  1999-08       Impact factor: 2.347

8.  Urinary excretion of pyridinium crosslinks of collagen in oophorectomized women as markers for bone resorption.

Authors:  K Hashimoto; M Nozaki; M Yokoyama; M Sano; H Nakano
Journal:  Maturitas       Date:  1994-02       Impact factor: 4.342

9.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

10.  Treatment of postmenopausal osteoporosis with transdermal estrogen.

Authors:  E G Lufkin; H W Wahner; W M O'Fallon; S F Hodgson; M A Kotowicz; A W Lane; H L Judd; R H Caplan; B L Riggs
Journal:  Ann Intern Med       Date:  1992-07-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.